Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 467

1.

The Me first communication model.

Martin K, Morton L, Reid J, Feltham A, Reid JW, Jeremy G, McCulloch J.

Nurs Child Young People. 2019 Mar 4. doi: 10.7748/ncyp.2019.e1064. [Epub ahead of print]

PMID:
31468939
2.

The Me first communication model.

Martin K, Morton L, Reid J, Feltham A, William Reid J, Jeremy G, McCulloch J.

Nurs Child Young People. 2019 Mar 6;31(2):38-47. doi: 10.7748/ncyp.2019.e1064.

PMID:
31468770
3.

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.

Din L, Sheikh M, Kosaraju N, Smedby KE, Bernatsky S, Berndt SI, Skibola CF, Nieters A, Wang S, McKay JD, Cocco P, Maynadié M, Foretová L, Staines A, Mack TM, de Sanjosé S, Vyse TJ, Padyukov L, Monnereau A, Arslan AA, Moore A, Brooks-Wilson AR, Novak AJ, Glimelius B, Birmann BM, Link BK, Stewart C, Vajdic CM, Haioun C, Magnani C, Conti DV, Cox DG, Casabonne D, Albanes D, Kane E, Roman E, Muzi G, Salles G, Giles GG, Adami HO, Ghesquières H, De Vivo I, Clavel J, Cerhan JR, Spinelli JJ, Hofmann J, Vijai J, Curtin K, Costenbader KH, Onel K, Offit K, Teras LR, Morton L, Conde L, Miligi L, Melbye M, Ennas MG, Liebow M, Purdue MP, Glenn M, Southey MC, Din M, Rothman N, Camp NJ, Wong Doo N, Becker N, Pradhan N, Bracci PM, Boffetta P, Vineis P, Brennan P, Kraft P, Lan Q, Severson RK, Vermeulen RCH, Milne RL, Kaaks R, Travis RC, Weinstein SJ, Chanock SJ, Ansell SM, Slager SL, Zheng T, Zhang Y, Benavente Y, Taub Z, Madireddy L, Gourraud PA, Oksenberg JR, Cozen W, Hjalgrim H, Khankhanian P.

Genet Epidemiol. 2019 Aug 13. doi: 10.1002/gepi.22242. [Epub ahead of print]

PMID:
31407831
4.

Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study.

Advani PG, Schonfeld SJ, Curtis RE, Dores GM, Linet MS, Sigel BS, Lam CJK, Tucker MA, Chanock SJ, Morton LM.

Leukemia. 2019 Jul 24. doi: 10.1038/s41375-019-0520-y. [Epub ahead of print] No abstract available.

PMID:
31341236
5.

Using "outbreak science" to strengthen the use of models during epidemics.

Rivers C, Chretien JP, Riley S, Pavlin JA, Woodward A, Brett-Major D, Maljkovic Berry I, Morton L, Jarman RG, Biggerstaff M, Johansson MA, Reich NG, Meyer D, Snyder MR, Pollett S.

Nat Commun. 2019 Jul 15;10(1):3102. doi: 10.1038/s41467-019-11067-2. No abstract available.

6.

A dental student view on learning gained through Inter-Professional Engagement with people experiencing homelessness.

Webb L, Sandhu S, Morton L, Witton R, Withers L, Worle C, Paisi M.

Educ Prim Care. 2019 Jul 15:1-3. doi: 10.1080/14739879.2019.1636719. [Epub ahead of print]

PMID:
31307291
7.

Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.

Herr MM, Schonfeld SJ, Dores GM, Engels EA, Tucker MA, Curtis RE, Morton LM.

Blood Adv. 2019 Jul 9;3(13):1961-1969. doi: 10.1182/bloodadvances.2019030924.

8.

Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.

Moskowitz CS, Chou JF, Neglia JP, Partridge AH, Howell RM, Diller LR, Novetsky Friedman D, Barnea D, Morton LM, Turcotte LM, Arnold MA, Leisenring WM, Armstrong GT, Robison LL, Oeffinger KC, Henderson TO.

J Clin Oncol. 2019 Aug 20;37(24):2120-2130. doi: 10.1200/JCO.18.02219. Epub 2019 Jul 1.

PMID:
31260644
9.

Sex-related effect on immunotherapy response: implications and opportunities.

Colli LM, Morton LM, Chanock SJ.

J Natl Cancer Inst. 2019 May 20. pii: djz096. doi: 10.1093/jnci/djz096. [Epub ahead of print] No abstract available.

PMID:
31106816
10.

Implementing Chief Resident Immersion Training (CRIT) in the Care of Older Adults: Overcoming Barriers and Promoting Facilitators.

Furman CD, Wagner L, Gomes J, Gopalraj R, Parker BF, Morton L, Antimisiaris D, Neamtu D, Masroor S, Martin-Galijatovic R, Cotton S, Shaw MA.

Geriatrics (Basel). 2018 Sep 26;3(4). pii: E62. doi: 10.3390/geriatrics3040062.

11.

Confounding Factors in the Interpretation of Preclinical Studies.

Morton LD, Sanders M, Reagan WJ, Crabbs TA, McVean M, Funk KA.

Int J Toxicol. 2019 May/Jun;38(3):228-234. doi: 10.1177/1091581819837157. Epub 2019 Apr 11.

PMID:
30975012
12.

Genome-Wide Association Study in Irradiated Childhood Cancer Survivors Identifies HTR2A for Subsequent Basal Cell Carcinoma.

Sapkota Y, Turcotte LM, Ehrhardt MJ, Howell RM, Arnold MA, Wilson CL, Leisenring W, Wang Z, Sampson J, Dagnall CL, Karlins E, Li SA, Hicks BD, Weathers R, Smith SA, Shelton K, Liu Q, Tucker MA, Chanock SJ, Zhang J, Hudson MM, Neglia JP, Armstrong GT, Robison LL, Morton LM, Bhatia S, Yasui Y.

J Invest Dermatol. 2019 Sep;139(9):2042-2045.e8. doi: 10.1016/j.jid.2019.02.029. Epub 2019 Mar 22. No abstract available.

PMID:
30910758
13.

Defining the Activated Fibroblast Population in Lung Fibrosis Using Single-Cell Sequencing.

Peyser R, MacDonnell S, Gao Y, Cheng L, Kim Y, Kaplan T, Ruan Q, Wei Y, Ni M, Adler C, Zhang W, Devalaraja-Narashimha K, Grindley J, Halasz G, Morton L.

Am J Respir Cell Mol Biol. 2019 Jul;61(1):74-85. doi: 10.1165/rcmb.2018-0313OC.

PMID:
30848683
14.

Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients.

Mahale P, Engels EA, Lynch CF, Morton LM.

Br J Haematol. 2019 Jul;186(2):347-351. doi: 10.1111/bjh.15828. Epub 2019 Feb 28. No abstract available.

PMID:
30820931
15.

Using psychologically informed care to improve mental health and wellbeing for people living with a heart condition from birth: A statement paper.

Morton L.

J Health Psychol. 2019 Feb 7:1359105319826354. doi: 10.1177/1359105319826354. [Epub ahead of print]

16.

Patterns of Cause-Specific Mortality Among 2053 Survivors of Retinoblastoma, 1914-2016.

Kleinerman RA, Tucker MA, Sigel BS, Abramson DH, Seddon JM, Morton LM.

J Natl Cancer Inst. 2019 Jan 30. doi: 10.1093/jnci/djy227. [Epub ahead of print]

PMID:
30698734
17.

Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.

Kim J, Luo W, Wang M, Wegman-Ostrosky T, Frone MN, Johnston JJ, Nickerson ML, Rotunno M, Li SA, Achatz MI, Brodie SA, Dean M, de Andrade KC, Fortes FP, Gianferante M, Khincha P, McMaster ML, McReynolds LJ, Pemov A, Pinheiro M, Santiago KM, Alter BP, Caporaso NE, Gadalla SM, Goldin LR, Greene MH, Loud J, Yang XR, Freedman ND, Gapstur SM, Gaudet MM, Calista D, Ghiorzo P, Fargnoli MC, Nagore E, Peris K, Puig S, Landi MT, Hicks B, Zhu B, Liu J, Sampson JN, Chanock SJ, Mirabello LJ, Morton LM, Biesecker LG, Tucker MA, Savage SA, Goldstein AM, Stewart DR.

Genome Med. 2018 Dec 24;10(1):99. doi: 10.1186/s13073-018-0607-5.

18.

Combined α-programmed death-1 monoclonal antibody blockade and fractionated radiation therapy reduces tumor growth in mouse EL4 lymphoma.

Lin X, Zeng T, Xiong J, Zhang Q, Jiang P, Li X, Lin S, Xu Q, Weng H, Lai H, Gong H, Lin J, Cheng N, Tian X, Xu Y, Fang S, Jin R, Chen Z, Yang J, Morton L, Yueh B, Lin J.

Cancer Biol Ther. 2019;20(5):666-679. doi: 10.1080/15384047.2018.1550569. Epub 2018 Dec 20.

19.

Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.

Morton LM, Dores GM, Schonfeld SJ, Linet MS, Sigel BS, Lam CJK, Tucker MA, Curtis RE.

JAMA Oncol. 2019 Mar 1;5(3):318-325. doi: 10.1001/jamaoncol.2018.5625.

PMID:
30570657
20.

Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy.

Morton LM, Ricks-Santi L, West CML, Rosenstein BS.

Int J Part Ther. 2018 Summer;5(1):103-113. doi: 10.14338/IJPT-18-00009.1. Epub 2018 Sep 21.

21.

Initial beam emission spectroscopy diagnostic system on HL-2A tokamak.

Ke R, Wu YF, McKee GR, Yan Z, Jaehnig K, Xu M, Kriete M, Lu P, Wu T, Morton LA, Qin X, Song XM, Cao JY, Ding XT, Duan XR.

Rev Sci Instrum. 2018 Oct;89(10):10D122. doi: 10.1063/1.5039350.

PMID:
30399666
22.

Telomere Length-Associated Genetic Variants and the Risk of Thyroid Cancer in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study (CCSS).

Gramatges MM, Morton LM, Yasui Y, Arnold MA, Neglia JP, Leisenring WM, Machiela MJ, Dagnall CL, Chanock SJ, Armstrong GT, Robison LL, Bhatia S, Lupo PJ.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):417-419. doi: 10.1158/1055-9965.EPI-18-0972. Epub 2018 Oct 30.

PMID:
30377209
23.

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia.

McMaster ML, Berndt SI, Zhang J, Slager SL, Li SA, Vajdic CM, Smedby KE, Yan H, Birmann BM, Brown EE, Smith A, Kleinstern G, Fansler MM, Mayr C, Zhu B, Chung CC, Park JH, Burdette L, Hicks BD, Hutchinson A, Teras LR, Adami HO, Bracci PM, McKay J, Monnereau A, Link BK, Vermeulen RCH, Ansell SM, Maria A, Diver WR, Melbye M, Ojesina AI, Kraft P, Boffetta P, Clavel J, Giovannucci E, Besson CM, Canzian F, Travis RC, Vineis P, Weiderpass E, Montalvan R, Wang Z, Yeager M, Becker N, Benavente Y, Brennan P, Foretova L, Maynadie M, Nieters A, de Sanjose S, Staines A, Conde L, Riby J, Glimelius B, Hjalgrim H, Pradhan N, Feldman AL, Novak AJ, Lawrence C, Bassig BA, Lan Q, Zheng T, North KE, Tinker LF, Cozen W, Severson RK, Hofmann JN, Zhang Y, Jackson RD, Morton LM, Purdue MP, Chatterjee N, Offit K, Cerhan JR, Chanock SJ, Rothman N, Vijai J, Goldin LR, Skibola CF, Caporaso NE.

Nat Commun. 2018 Oct 10;9(1):4182. doi: 10.1038/s41467-018-06541-2.

24.

Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment.

Morton LM, Kerns SL, Dolan ME.

Am Soc Clin Oncol Educ Book. 2018 May 23;38:775-786. doi: 10.1200/EDBK_201391. Review.

25.

Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility.

Machiela MJ, Grünewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, Zaidi S, Grossetete-Lalami S, Ballet S, Lapouble E, Laurence V, Michon J, Pierron G, Kovar H, Gaspar N, Kontny U, González-Neira A, Picci P, Alonso J, Patino-Garcia A, Corradini N, Bérard PM, Freedman ND, Rothman N, Dagnall CL, Burdett L, Jones K, Manning M, Wyatt K, Zhou W, Yeager M, Cox DG, Hoover RN, Khan J, Armstrong GT, Leisenring WM, Bhatia S, Robison LL, Kulozik AE, Kriebel J, Meitinger T, Metzler M, Hartmann W, Strauch K, Kirchner T, Dirksen U, Morton LM, Mirabello L, Tucker MA, Tirode F, Chanock SJ, Delattre O.

Nat Commun. 2018 Aug 9;9(1):3184. doi: 10.1038/s41467-018-05537-2.

26.

Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition.

Lang D, Schott BH, van Ham M, Morton L, Kulikovskaja L, Herrera-Molina R, Pielot R, Klawonn F, Montag D, Jänsch L, Gundelfinger ED, Smalla KH, Dunay IR.

J Neuroinflammation. 2018 Aug 1;15(1):216. doi: 10.1186/s12974-018-1242-1.

27.

Beliefs about back pain and pain management behaviours, and their associations in the general population: A systematic review.

Morton L, de Bruin M, Krajewska M, Whibley D, Macfarlane GJ.

Eur J Pain. 2019 Jan;23(1):15-30. doi: 10.1002/ejp.1285. Epub 2018 Aug 7.

28.

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies.

Thanarajasingam G, Minasian LM, Baron F, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gribben J, Horowitz M, Ivy SP, Jacobson CA, Keating A, Kluetz PG, Krauss A, Kwong YL, Little RF, Mahon FX, Matasar MJ, Mateos MV, McCullough K, Miller RS, Mohty M, Moreau P, Morton LM, Nagai S, Rule S, Sloan J, Sonneveld P, Thompson CA, Tzogani K, van Leeuwen FE, Velikova G, Villa D, Wingard JR, Wintrich S, Seymour JF, Habermann TM.

Lancet Haematol. 2018 Nov;5(11):e563-e598. doi: 10.1016/S2352-3026(18)30051-6. Epub 2018 Jun 18. Review. Erratum in: Lancet Haematol. 2019 Mar;6(3):e121.

29.

Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review.

Turcotte LM, Neglia JP, Reulen RC, Ronckers CM, van Leeuwen FE, Morton LM, Hodgson DC, Yasui Y, Oeffinger KC, Henderson TO.

J Clin Oncol. 2018 Jul 20;36(21):2145-2152. doi: 10.1200/JCO.2017.76.7764. Epub 2018 Jun 6.

30.

Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.

Zhang R, Kramer JS, Smith JD, Allen BN, Leeper CN, Li X, Morton LD, Gallazzi F, Ulery BD.

AAPS J. 2018 Jun 1;20(4):73. doi: 10.1208/s12248-018-0233-6.

PMID:
29858738
31.

Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.

Teepen JC, Curtis RE, Dores GM, Berrington de Gonzalez A, van den Heuvel-Eibrink MM, Kremer LCM, Gilbert ES, van Leeuwen FE, Ronckers CM, Morton LM.

Leukemia. 2018 Dec;32(12):2580-2589. doi: 10.1038/s41375-018-0149-2. Epub 2018 May 24.

PMID:
29795414
32.

HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.

Wang SS, Carrington M, Berndt SI, Slager SL, Bracci PM, Voutsinas J, Cerhan JR, Smedby KE, Hjalgrim H, Vijai J, Morton LM, Vermeulen R, Paltiel O, Vajdic CM, Linet MS, Nieters A, de Sanjose S, Cozen W, Brown EE, Turner J, Spinelli JJ, Zheng T, Birmann BM, Flowers CR, Becker N, Holly EA, Kane E, Weisenburger D, Maynadie M, Cocco P, Albanes D, Weinstein SJ, Teras LR, Diver WR, Lax SJ, Travis RC, Kaaks R, Riboli E, Benavente Y, Brennan P, McKay J, Delfau-Larue MH, Link BK, Magnani C, Ennas MG, Latte G, Feldman AL, Doo NW, Giles GG, Southey MC, Milne RL, Offit K, Musinsky J, Arslan AA, Purdue MP, Adami HO, Melbye M, Glimelius B, Conde L, Camp NJ, Glenn M, Curtin K, Clavel J, Monnereau A, Cox DG, Ghesquières H, Salles G, Bofetta P, Foretova L, Staines A, Davis S, Severson RK, Lan Q, Brooks-Wilson A, Smith MT, Roman E, Kricker A, Zhang Y, Kraft P, Chanock SJ, Rothman N, Hartge P, Skibola CF.

Cancer Res. 2018 Jul 15;78(14):4086-4096. doi: 10.1158/0008-5472.CAN-17-2900. Epub 2018 May 7.

33.

A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies.

Rosskopf S, Leitner J, Paster W, Morton LT, Hagedoorn RS, Steinberger P, Heemskerk MHM.

Oncotarget. 2018 Apr 3;9(25):17608-17619. doi: 10.18632/oncotarget.24807. eCollection 2018 Apr 3.

34.

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.

Kleinstern G, Camp NJ, Goldin LR, Vachon CM, Vajdic CM, de Sanjose S, Weinberg JB, Benavente Y, Casabonne D, Liebow M, Nieters A, Hjalgrim H, Melbye M, Glimelius B, Adami HO, Boffetta P, Brennan P, Maynadie M, McKay J, Cocco PL, Shanafelt TD, Call TG, Norman AD, Hanson C, Robinson D, Chaffee KG, Brooks-Wilson AR, Monnereau A, Clavel J, Glenn M, Curtin K, Conde L, Bracci PM, Morton LM, Cozen W, Severson RK, Chanock SJ, Spinelli JJ, Johnston JB, Rothman N, Skibola CF, Leis JF, Kay NE, Smedby KE, Berndt SI, Cerhan JR, Caporaso N, Slager SL.

Blood. 2018 Jun 7;131(23):2541-2551. doi: 10.1182/blood-2017-11-814608. Epub 2018 Apr 19.

35.

Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.

Herr MM, Schonfeld SJ, Dores GM, Withrow DR, Tucker MA, Curtis RE, Morton LM.

J Natl Cancer Inst. 2018 Nov 1;110(11):1248-1258. doi: 10.1093/jnci/djy052.

36.

Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays.

Dagnall CL, Morton LM, Hicks BD, Li S, Zhou W, Karlins E, Teshome K, Chowdhury S, Lashley KS, Sampson JN, Robison LL, Armstrong GT, Bhatia S, Radloff GA, Davies SM, Tucker MA, Yeager M, Chanock SJ.

BMC Genomics. 2018 Mar 6;19(1):182. doi: 10.1186/s12864-018-4572-6.

37.

A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy.

Brooke RJ, Im C, Wilson CL, Krasin MJ, Liu Q, Li Z, Sapkota Y, Moon W, Morton LM, Wu G, Wang Z, Chen W, Howell RM, Armstrong GT, Bhatia S, Mostoufi-Moab S, Seidel K, Chanock SJ, Zhang J, Green DM, Sklar CA, Hudson MM, Robison LL, Chemaitilly W, Yasui Y.

J Natl Cancer Inst. 2018 Aug 1;110(8):895-904. doi: 10.1093/jnci/djx281.

38.

Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers.

Withrow DR, Morton LM, Curtis RE, Schonfeld SJ, Berrington de González A.

JAMA Oncol. 2018 Mar 1;4(3):414-416. doi: 10.1001/jamaoncol.2017.4887. No abstract available.

39.

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma.

Bernatsky S, Velásquez García HA, Spinelli JJ, Gaffney P, Smedby KE, Ramsey-Goldman R, Wang SS, Adami HO, Albanes D, Angelucci E, Ansell SM, Asmann YW, Becker N, Benavente Y, Berndt SI, Bertrand KA, Birmann BM, Boeing H, Boffetta P, Bracci PM, Brennan P, Brooks-Wilson AR, Cerhan JR, Chanock SJ, Clavel J, Conde L, Cotenbader KH, Cox DG, Cozen W, Crouch S, De Roos AJ, de Sanjose S, Di Lollo S, Diver WR, Dogan A, Foretova L, Ghesquières H, Giles GG, Glimelius B, Habermann TM, Haioun C, Hartge P, Hjalgrim H, Holford TR, Holly EA, Jackson RD, Kaaks R, Kane E, Kelly RS, Klein RJ, Kraft P, Kricker A, Lan Q, Lawrence C, Liebow M, Lightfoot T, Link BK, Maynadie M, McKay J, Melbye M, Molina TJ, Monnereau A, Morton LM, Nieters A, North KE, Novak AJ, Offit K, Purdue MP, Rais M, Riby J, Roman E, Rothman N, Salles G, Severi G, Severson RK, Skibola CF, Slager SL, Smith A, Smith MT, Southey MC, Staines A, Teras LR, Thompson CA, Tilly H, Tinker LF, Tjonneland A, Turner J, Vajdic CM, Vermeulen RCH, Vijai J, Vineis P, Virtamo J, Wang Z, Weinstein S, Witzig TE, Zelenetz A, Zeleniuch-Jacquotte A, Zhang Y, Zheng T, Zucca M, Clarke AE.

Lupus Sci Med. 2017 Nov 12;4(1):e000187. doi: 10.1136/lupus-2016-000187. eCollection 2017.

40.

Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.

Morton LM, Sampson JN, Armstrong GT, Chen TH, Hudson MM, Karlins E, Dagnall CL, Li SA, Wilson CL, Srivastava DK, Liu W, Kang G, Oeffinger KC, Henderson TO, Moskowitz CS, Gibson TM, Merino DM, Wong JR, Hammond S, Neglia JP, Turcotte LM, Miller J, Bowen L, Wheeler WA, Leisenring WM, Whitton JA, Burdette L, Chung C, Hicks BD, Jones K, Machiela MJ, Vogt A, Wang Z, Yeager M, Neale G, Lear M, Strong LC, Yasui Y, Stovall M, Weathers RE, Smith SA, Howell R, Davies SM, Radloff GA, Onel K, Berrington de González A, Inskip PD, Rajaraman P, Fraumeni JF Jr, Bhatia S, Chanock SJ, Tucker MA, Robison LL.

J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx058.

41.

Surgical and social implications of extraction of mandibular third molars as a separate procedure before bilateral sagittal split osteotomy.

Morton L, Downie I.

Br J Oral Maxillofac Surg. 2017 Nov;55(9):937-939. doi: 10.1016/j.bjoms.2017.09.004. Epub 2017 Oct 18.

PMID:
29055570
42.

A NOVEL METHOD TO ESTIMATE LYMPHOCYTE DOSE AND APPLICATION TO PEDIATRIC AND YOUNG ADULT CT PATIENTS IN THE UNITED KINGDOM.

Lee C, Morton LM, de Gonzalez AB.

Radiat Prot Dosimetry. 2018 Jan 1;178(1):116-121. doi: 10.1093/rpd/ncx084.

43.

Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity.

Agrawal S, Moser KA, Morton L, Cummings MP, Parihar A, Dwivedi A, Shetty AC, Drabek EF, Jacob CG, Henrich PP, Parobek CM, Jongsakul K, Huy R, Spring MD, Lanteri CA, Chaorattanakawee S, Lon C, Fukuda MM, Saunders DL, Fidock DA, Lin JT, Juliano JJ, Plowe CV, Silva JC, Takala-Harrison S.

J Infect Dis. 2017 Aug 15;216(4):468-476. doi: 10.1093/infdis/jix334.

44.

Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis.

Loarca L, De Assuncao TM, Jalan-Sakrikar N, Bronk S, Krishnan A, Huang B, Morton L, Trussoni C, Bonilla LM, Krueger E, O'Hara S, Splinter P, Shi G, Pisarello MJL, Gores GJ, Huebert RC, LaRusso NF.

Lab Invest. 2017 Nov;97(11):1385-1396. doi: 10.1038/labinvest.2017.63. Epub 2017 Sep 11.

45.

Tamoxifen Pharmacovigilance: Implications for Safe Use in the Future.

Antimisiaris D, Bae KG, Morton L, Gully Z.

Consult Pharm. 2017 Sep 1;32(9):535-546. doi: 10.4140/TCP.n.2017.535.

46.

The Urgent Need for Robust Geriatric Patient Care Skills in Primary Care.

Antimisiaris D, Morton L.

Prim Care. 2017 Sep;44(3):xv-xvi. doi: 10.1016/j.pop.2017.06.001. No abstract available.

PMID:
28797381
47.

Sexuality in the Older Adult.

Morton L.

Prim Care. 2017 Sep;44(3):429-438. doi: 10.1016/j.pop.2017.04.004. Epub 2017 Jul 18. Review.

PMID:
28797370
48.

Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers.

Withrow DR, Morton LM, Curtis RE, Schonfeld SJ, Berrington de González A.

Breast Cancer Res Treat. 2017 Nov;166(1):299-306. doi: 10.1007/s10549-017-4410-6. Epub 2017 Jul 25.

PMID:
28744752
49.

What's Trending in Infection Control? Scoping and Narrative Reviews.

Mitchell BG, Petrie D, Morton L, Dancer SJ.

Infect Control Hosp Epidemiol. 2017 Sep;38(9):1098-1102. doi: 10.1017/ice.2017.130. Epub 2017 Jul 11.

PMID:
28693642
50.

Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.

Zamoiski RD, Yanik E, Gibson TM, Cahoon EK, Madeleine MM, Lynch CF, Gustafson S, Goodman MT, Skeans M, Israni AK, Engels EA, Morton LM.

Cancer Res. 2017 Aug 1;77(15):4196-4203. doi: 10.1158/0008-5472.CAN-16-3291. Epub 2017 Jun 14.

Supplemental Content

Loading ...
Support Center